This is in accord with previous observations detecting increases in AEA rather than 2-AG in models of cerebral ischemia [61] and with previous results showing that CB1 agonists exacerbate OGD injury whereas CB1 antagonists are neuroprotective in this model [44]. This evidence concerns the gene CNR1 and brain ischemia.